scholarly article | Q13442814 |
P2093 | author name string | Alain R M Townsend | |
Hal Drakesmith | |||
Alison T Merryweather-Clarke | |||
Kathryn J H Robson | |||
Vip Viprakasit | |||
Yingyong Chinthammitr | |||
Emma Ormerod | |||
Lisa M Schimanski | |||
Diana Cowley | |||
Emma Sweetland | |||
Jon P Edwards | |||
Judy M Bastin | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1092-7 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin | |
P478 | volume | 106 |
Q37716856 | "Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels |
Q88742047 | A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign |
Q51004546 | A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B. |
Q45905043 | A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro. |
Q39643628 | An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. |
Q39953240 | Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation |
Q33728846 | Ceruloplasmin-ferroportin system of iron traffic in vertebrates |
Q84950080 | Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation |
Q37021503 | Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations |
Q38368101 | Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients. |
Q39118388 | Design, synthesis, and characterization of cyclic analogues of the iron regulatory peptide hormone hepcidin |
Q34483947 | EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). |
Q36776654 | Effect of SNPs on iron metabolism |
Q35642812 | Evidence for the multimeric structure of ferroportin |
Q37770457 | Factors influencing disease phenotype and penetrance in HFE haemochromatosis. |
Q34065915 | Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children. |
Q36014787 | Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption. |
Q42026727 | Ferroportin and Erythroid Cells: An Update |
Q34209183 | Ferroportin disease: a systematic meta-analysis of clinical and molecular findings |
Q47109362 | Ferroportin disease: pathogenesis, diagnosis and treatment. |
Q47783604 | Ferroportin diseases: functional studies, a link between genetic and clinical phenotype |
Q36742479 | Forging a field: the golden age of iron biology |
Q39784883 | Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. |
Q33702877 | Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc |
Q39629166 | G80S-linked ferroportin disease: Classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective |
Q50335665 | Genetic and clinical heterogeneity of ferroportin disease |
Q37633932 | Genetic mechanisms and modifying factors in hereditary hemochromatosis. |
Q88273092 | Haemochromatosis |
Q30251784 | Haemochromatosis. |
Q44457164 | Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types |
Q37929067 | Hepcidin and ferroportin: the new players in iron metabolism |
Q34499129 | Hepcidin induces HIV-1 transcription inhibited by ferroportin |
Q34571768 | Hepcidin--central regulator of iron metabolism |
Q37129387 | Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. |
Q36456044 | Hepcidin: an important new regulator of iron homeostasis |
Q42561633 | Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation |
Q24646056 | Hereditary hemochromatosis in the post-HFE era |
Q33526618 | High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine |
Q34356504 | Host-mediated regulation of superinfection in malaria |
Q38813097 | How we manage patients with hereditary haemochromatosis |
Q33628733 | Human macrophage ferroportin biology and the basis for the ferroportin disease |
Q28294061 | Impaired iron transport activity of ferroportin 1 in hereditary iron overload |
Q46985588 | In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation |
Q35828757 | Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin |
Q91654887 | Inherited iron overload disorders |
Q30487384 | Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter |
Q60955833 | Iron Regulation: Macrophages in Control |
Q37087636 | Iron homeostasis and erythropoiesis |
Q34651570 | Iron imports. IV. Hepcidin and regulation of body iron metabolism |
Q36376662 | Iron overload due to mutations in ferroportin. |
Q56487598 | Iron storage disease (hemochromatosis) and hepcidin response to iron load in two species of pteropodid fruit bats relative to the common vampire bat |
Q38098239 | Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations. |
Q26828803 | Iron, anemia and hepcidin in malaria |
Q34671956 | Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin. |
Q28087429 | Ironing out Ferroportin |
Q36396704 | Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response |
Q36177913 | Liver iron transport |
Q84373935 | Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders |
Q26861531 | Mechanistic and regulatory aspects of intestinal iron absorption |
Q43082361 | Molecular and clinical correlates in iron overload associated with mutations in ferroportin. |
Q37737808 | Molecular basis of hereditary iron homeostasis defects |
Q37789031 | Molecular diagnosis of genetic iron-overload disorders |
Q34516972 | New insights into the regulation of iron homeostasis |
Q36822684 | Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection |
Q34480045 | Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4. |
Q37969729 | Obesity and iron deficiency in chronic kidney disease: the putative role of hepcidin. |
Q34650865 | Of mice and men: the iron age. |
Q39179833 | Overview of iron metabolism in health and disease |
Q24654441 | Pathophysiology of hereditary hemochromatosis |
Q46931196 | Prevalence of HFE mutations in California newborns |
Q30413289 | Protein degradation and iron homeostasis |
Q37139716 | RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved |
Q36259666 | Recent advances in intestinal iron transport |
Q36862359 | Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin |
Q26852319 | Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation |
Q37320318 | Regulation of iron absorption in hemoglobinopathies. |
Q36995110 | Regulation of iron acquisition and storage: consequences for iron-linked disorders |
Q36839068 | Role of cellular iron and oxygen in the regulation of HIV-1 infection |
Q24682642 | SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent |
Q57036638 | Structural and functional abnormalities in iron-depleted heart |
Q98567975 | Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms |
Q46152147 | Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin |
Q39137463 | Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues. |
Q35632820 | Superinfection in malaria: Plasmodium shows its iron will |
Q93159561 | The Importance of Iron Status for Young Children in Low- and Middle-Income Countries: A Narrative Review |
Q59810086 | The R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism |
Q37543492 | The Regulation of Iron Absorption and Homeostasis |
Q48168878 | The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation. |
Q90089158 | The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia |
Q24678328 | The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease |
Q37356785 | The global burden of iron overload |
Q40290550 | The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica |
Q37271055 | The molecular basis of hepcidin-resistant hereditary hemochromatosis |
Q37826382 | The molecular basis of iron overload disorders and iron-linked anemias |
Q38316682 | The molecular circuitry regulating the switch between iron deficiency and overload in mice |
Q36244891 | The molecular genetics of haemochromatosis. |
Q35901835 | The molecular mechanism of hepcidin-mediated ferroportin down-regulation |
Q24810582 | Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes |
Q43171586 | Towards explaining "unexplained hyperferritinemia". |
Q90041254 | Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features |
Q42026895 | Wild-type and mutant ferroportins do not form oligomers in transfected cells. |
Q36141710 | Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations |
Search more.